---
type: "Nootropic"
title: "Mucuna Pruriens"
description: "Mucuna pruriens seeds contain levodopa. Preparations and L-DOPA content vary. Parkinson’s and infertility studies do not establish a motivation benefit in healthy people."
resource: "https://nootropikler.com/nootropics/mucuna-pruriens"
tags: ["dopamine", "motivation", "Mood"]
timestamp: 2026-11-11T00:00:00Z
category: "Mood"
source: "Natural"
latin: "Mucuna pruriens (Kılıçkını)"
language: "en"
---

# Mucuna Pruriens

*Mucuna pruriens (Kılıçkını)*

Mucuna pruriens seeds contain levodopa. Preparations and L-DOPA content vary. Parkinson’s and infertility studies do not establish a motivation benefit in healthy people.

## Quick profile

| Property | Value |
| --- | --- |
| Onset of Effect | No established timeframe |
| Half life | Depends on the constituent and extract |
| Dose used in research | Determined by the prescriber |
| Safety | See detailed safety warnings |
| Level of Evidence | Sınırlı |

> Correction · 2026-11-11: Removed the motivation claim for healthy people and the generalized half-life. Separated the Parkinson’s trial from product measurements.

## What is Mucuna Pruriens?

Mucuna pruriens is a tropical legume plant known as "Atmagupta" or "Kapikachhu" in Indian traditional medicine (Ayurveda). It grows naturally in the temperate regions of India, Africa and the Caribbean. It has been used in Ayurveda for thousands of years for nervous system support, male fertility and vitality.

Levodopa is a dopamine precursor. Its presence in seeds or extracts does not establish cognitive benefit in healthy people.

## Mechanism of Effect

> **⚠ Pharmacological Potency - Drug Interaction Warning:** Since Mucuna contains a direct dopamine precursor, it may have serious pharmacodynamic interactions with Parkinson's drugs (Carbidopa/Levodopa combinations). In addition, concomitant use with MAO inhibitors, antipsychotics and other dopaminergic agents may be dangerous. Individuals using any medication should NEVER start Mucuna supplements without obtaining doctor's approval.

## Clinical Evidence

Clinical research on Mucuna pruriens focuses on two main areas: Parkinson's disease and male fertility.

**Katzenschlager et al. (2004)** compared single 15/30 g doses of Mucuna seed preparation with levodopa/carbidopa in eight Parkinson patients. The 30 g preparation had faster onset and longer “on” time; **dyskinesia and tolerability did not differ significantly**. This small single-dose study does not establish superior long-term safety.

Shukla et al. (2010) used 5 g/day **seed powder** for three months in infertile men; this is not 5 g of a 15% L-DOPA standardized extract or a 750 mg L-DOPA dose. Findings in this patient group do not establish a safe/effective starting dose for mood or motivation in healthy people. L-DOPA content can vary between products; clinical assessment is needed.

## Dose information and research limits

The range applies to the tested samples. It does not establish the content, clinical effects or safe dose of other products or batches.


## Frequently Asked Questions

### What is Mucuna pruriens used for?

Mucuna pruriens seeds contain levodopa. Preparations and L-DOPA content vary. Parkinson’s and infertility studies do not establish a motivation benefit in healthy people.

### What is the recommended dosage for Mucuna pruriens?

Shukla et al. (2010) used 5 g/day **seed powder** for three months in infertile men; this is not 5 g of a 15% L-DOPA standardized extract or a 750 mg L-DOPA dose. Findings in this patient group do not establish a safe/effective starting dose for mood or motivation in healthy people. L-DOPA content can vary between products; clinical assessment is needed.

### What are the side effects of Mucuna pruriens?

RIVM notes that levodopa in Mucuna supplements may cause gastrointestinal symptoms, involuntary movements and psychiatric symptoms. RIVM advises avoiding these supplements during pregnancy, breastfeeding or in case of liver or kidney problems.

### Is Mucuna pruriens legal in Türkiye and where can it be found?

Sale and import status in Türkiye must be checked for the specific product. Verify supplement approval in the Ministry of Agriculture and Forestry GGBS list, and medicine authorization and conditions of use in TİTCK records. Online availability does not establish approval or unrestricted personal import; current Ministry of Trade conditions apply to postal and express shipments.

### When does the effect of Mucuna pruriens begin?

No established timeframe

## Sources

- Katzenschlager R, et al. (2004). Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study. *Journal of Neurology, Neurosurgery & Psychiatry*, 75(12), 1672–1677. [PubMed · PMID 15548480](https://pubmed.ncbi.nlm.nih.gov/15548480/)
- Shukla KK, et al. (2009). Mucuna pruriens improves male fertility by its action on the hypothalamus-pituitary-gonadal axis. *Fertility and Sterility*, 92(6), 1934–1940. [PubMed · PMID 18973898](https://pubmed.ncbi.nlm.nih.gov/18973898/)
- Lieu CA, et al. (2010). A water extract of Mucuna pruriens provides long-term amelioration of parkinsonism with reduced risk for dyskinesias. *Parkinsonism & Related Disorders*, 16(7), 458–465. [PubMed · PMID 20570206](https://pubmed.ncbi.nlm.nih.gov/20570206/)
- Manyam BV, et al. (2004). Neuroprotective effects of the antiparkinson drug Mucuna pruriens. *Phytotherapy Research*, 18(9), 706–12. https://doi.org/10.1002/ptr.1514 [PubMed · PMID 15478206](https://pubmed.ncbi.nlm.nih.gov/15478206/)
- Shukla KK, et al. (2010). Mucuna pruriens Reduces Stress and Improves the Quality of Semen in Infertile Men. *Evidence-Based Complementary and Alternative Medicine*, 7(1), 137–144. https://doi.org/10.1093/ecam/nem171 [PubMed · PMID 18955292](https://pubmed.ncbi.nlm.nih.gov/18955292/)
- Cohen PA, et al. (2022). Levodopa Content of Mucuna pruriens Supplements in the NIH Dietary Supplement Label Database. *JAMA Neurology*, 79(10), 1085–1086. https://doi.org/10.1001/jamaneurol.2022.2184 [PubMed · PMID 35939305](https://pubmed.ncbi.nlm.nih.gov/35939305/)
- T.C. Tarım ve Orman Bakanlığı. Bir takviye edici gıdanın onaylı olup olmadığını nereden öğrenebiliriz? (2026). https://guvenilirgida.tarimorman.gov.tr/Haber/Detay/17314 [T.C. Tarım ve Orman Bakanlığı](https://guvenilirgida.tarimorman.gov.tr/Haber/Detay/17314)
- Netherlands National Institute for Public Health and the Environment (RIVM). (2024). Risk assessment of herbal preparations containing seed extracts of Mucuna pruriens. Report 2024-0087. https://www.rivm.nl/publicaties/risk-assessment-of-herbal-preparations-containing-seed-extracts-of-mucuna-pruriens [Netherlands National Institute for Public Health and the Environment (RIVM)](https://www.rivm.nl/publicaties/risk-assessment-of-herbal-preparations-containing-seed-extracts-of-mucuna-pruriens)

## Related nootropics

- [N-Acetyl L-Tyrosine](/okf/nootropics/n-acetyl-l-tyrosine.md)
- [5-HTP](/okf/nootropics/5-htp.md)
- [rhodiola rosea](/okf/nootropics/rhodiola-rosea.md)
